vs
Martin Marietta Materials（MLM）与Steris（STE）财务数据对比。点击上方公司名可切换其他公司
Steris的季度营收约是Martin Marietta Materials的1.1倍（$1.5B vs $1.4B），Martin Marietta Materials净利率更高（111.1% vs 12.9%，领先98.2%），Martin Marietta Materials同比增速更快（17.0% vs 9.2%），过去两年Steris的营收复合增速更高（15.8% vs -12.1%）
马丁·玛丽埃塔材料公司是美国大型集料及重型建筑材料供应商，业务覆盖美国26个州、加拿大及加勒比地区，主要为道路、人行道、地基等各类基建项目提供所需原材料。
Steris plc是一家美爱合资的医疗设备企业，专注于为美国医疗体系提供灭菌服务及外科手术相关产品。其实际运营总部位于美国俄亥俄州门托市，深耕医疗消毒、感染防控、手术耗材等领域，为医疗机构提供专业可靠的医疗解决方案。
MLM vs STE — 直观对比
营收规模更大
STE
是对方的1.1倍
$1.4B
营收增速更快
MLM
高出7.8%
9.2%
净利率更高
MLM
高出98.2%
12.9%
两年增速更快
STE
近两年复合增速
-12.1%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.4B | $1.5B |
| 净利润 | $1.5B | $192.9M |
| 毛利率 | 22.8% | 43.8% |
| 营业利润率 | 11.9% | 18.3% |
| 净利率 | 111.1% | 12.9% |
| 营收同比 | 17.0% | 9.2% |
| 净利润同比 | — | 11.2% |
| 每股收益（稀释后） | — | $1.96 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MLMSTE
| Q1 26 | $1.4B | — | ||
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.8B | $1.5B | ||
| Q2 25 | $1.8B | $1.4B | ||
| Q1 25 | $1.4B | $1.5B | ||
| Q4 24 | $1.6B | $1.4B | ||
| Q3 24 | $1.9B | $1.3B | ||
| Q2 24 | $1.8B | $1.3B |
净利润MLMSTE
| Q1 26 | $1.5B | — | ||
| Q4 25 | $279.0M | $192.9M | ||
| Q3 25 | $414.0M | $191.9M | ||
| Q2 25 | $328.0M | $177.4M | ||
| Q1 25 | $116.0M | $145.7M | ||
| Q4 24 | $293.0M | $173.5M | ||
| Q3 24 | $363.0M | $150.0M | ||
| Q2 24 | $294.0M | $145.4M |
毛利率MLMSTE
| Q1 26 | 22.8% | — | ||
| Q4 25 | 35.0% | 43.8% | ||
| Q3 25 | 33.1% | 44.2% | ||
| Q2 25 | 30.0% | 45.1% | ||
| Q1 25 | 24.8% | 43.3% | ||
| Q4 24 | 30.0% | 44.5% | ||
| Q3 24 | 31.7% | 43.6% | ||
| Q2 24 | 29.3% | 44.7% |
营业利润率MLMSTE
| Q1 26 | 11.9% | — | ||
| Q4 25 | 24.6% | 18.3% | ||
| Q3 25 | 27.4% | 18.2% | ||
| Q2 25 | 25.3% | 17.7% | ||
| Q1 25 | 14.3% | 14.6% | ||
| Q4 24 | 24.4% | 17.9% | ||
| Q3 24 | 25.9% | 16.5% | ||
| Q2 24 | 22.6% | 14.5% |
净利率MLMSTE
| Q1 26 | 111.1% | — | ||
| Q4 25 | 24.5% | 12.9% | ||
| Q3 25 | 22.4% | 13.1% | ||
| Q2 25 | 18.1% | 12.8% | ||
| Q1 25 | 8.6% | 9.8% | ||
| Q4 24 | 18.0% | 12.7% | ||
| Q3 24 | 19.2% | 11.3% | ||
| Q2 24 | 16.7% | 11.4% |
每股收益（稀释后）MLMSTE
| Q1 26 | — | — | ||
| Q4 25 | $4.59 | $1.96 | ||
| Q3 25 | $6.85 | $1.94 | ||
| Q2 25 | $5.43 | $1.79 | ||
| Q1 25 | $1.90 | $1.48 | ||
| Q4 24 | $4.87 | $1.75 | ||
| Q3 24 | $5.91 | $1.51 | ||
| Q2 24 | $4.76 | $1.46 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $273.0M | $423.7M |
| 总债务越低越好 | $0 | $1.9B |
| 股东权益账面价值 | $11.3B | $7.2B |
| 总资产 | $20.5B | $10.6B |
| 负债/权益比越低杠杆越低 | 0.00× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资MLMSTE
| Q1 26 | $273.0M | — | ||
| Q4 25 | $67.0M | $423.7M | ||
| Q3 25 | $57.0M | $319.2M | ||
| Q2 25 | $225.0M | $279.7M | ||
| Q1 25 | $101.0M | $171.7M | ||
| Q4 24 | $670.0M | $155.2M | ||
| Q3 24 | $52.0M | $172.2M | ||
| Q2 24 | $109.0M | $198.3M |
总债务MLMSTE
| Q1 26 | $0 | — | ||
| Q4 25 | $5.3B | $1.9B | ||
| Q3 25 | $5.5B | $1.9B | ||
| Q2 25 | $5.4B | $1.9B | ||
| Q1 25 | $5.4B | $1.9B | ||
| Q4 24 | $5.4B | $2.0B | ||
| Q3 24 | $4.0B | $2.2B | ||
| Q2 24 | $4.3B | $2.2B |
股东权益MLMSTE
| Q1 26 | $11.3B | — | ||
| Q4 25 | $10.0B | $7.2B | ||
| Q3 25 | $9.7B | $7.0B | ||
| Q2 25 | $9.4B | $7.0B | ||
| Q1 25 | $9.1B | $6.6B | ||
| Q4 24 | $9.5B | $6.4B | ||
| Q3 24 | $9.2B | $6.6B | ||
| Q2 24 | $8.8B | $6.4B |
总资产MLMSTE
| Q1 26 | $20.5B | — | ||
| Q4 25 | $18.7B | $10.6B | ||
| Q3 25 | $18.7B | $10.4B | ||
| Q2 25 | $18.1B | $10.4B | ||
| Q1 25 | $17.7B | $10.1B | ||
| Q4 24 | $18.2B | $10.0B | ||
| Q3 24 | $16.5B | $10.2B | ||
| Q2 24 | $16.3B | $10.1B |
负债/权益比MLMSTE
| Q1 26 | 0.00× | — | ||
| Q4 25 | 0.53× | 0.27× | ||
| Q3 25 | 0.57× | 0.27× | ||
| Q2 25 | 0.58× | 0.27× | ||
| Q1 25 | 0.60× | 0.29× | ||
| Q4 24 | 0.57× | 0.32× | ||
| Q3 24 | 0.44× | 0.33× | ||
| Q2 24 | 0.49× | 0.35× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $227.0M | $298.2M |
| 自由现金流经营现金流 - 资本支出 | — | $199.5M |
| 自由现金流率自由现金流/营收 | — | 13.3% |
| 资本支出强度资本支出/营收 | 40.4% | 6.6% |
| 现金转化率经营现金流/净利润 | 0.15× | 1.55× |
| 过去12个月自由现金流最近4个季度 | — | $917.1M |
8季度趋势，按日历期对齐
经营现金流MLMSTE
| Q1 26 | $227.0M | — | ||
| Q4 25 | $629.0M | $298.2M | ||
| Q3 25 | $551.0M | $287.8M | ||
| Q2 25 | $387.0M | $420.0M | ||
| Q1 25 | $218.0M | $260.8M | ||
| Q4 24 | $686.0M | $332.8M | ||
| Q3 24 | $600.0M | $250.7M | ||
| Q2 24 | $1.0M | $303.7M |
自由现金流MLMSTE
| Q1 26 | — | — | ||
| Q4 25 | $424.0M | $199.5M | ||
| Q3 25 | $361.0M | $201.3M | ||
| Q2 25 | $208.0M | $326.4M | ||
| Q1 25 | $-15.0M | $189.9M | ||
| Q4 24 | $453.0M | $243.6M | ||
| Q3 24 | $317.0M | $148.8M | ||
| Q2 24 | $-138.0M | $195.7M |
自由现金流率MLMSTE
| Q1 26 | — | — | ||
| Q4 25 | 37.2% | 13.3% | ||
| Q3 25 | 19.6% | 13.8% | ||
| Q2 25 | 11.5% | 23.5% | ||
| Q1 25 | -1.1% | 12.8% | ||
| Q4 24 | 27.8% | 17.8% | ||
| Q3 24 | 16.8% | 11.2% | ||
| Q2 24 | -7.8% | 15.3% |
资本支出强度MLMSTE
| Q1 26 | 40.4% | — | ||
| Q4 25 | 18.0% | 6.6% | ||
| Q3 25 | 10.3% | 5.9% | ||
| Q2 25 | 9.9% | 6.7% | ||
| Q1 25 | 17.2% | 4.8% | ||
| Q4 24 | 14.3% | 6.5% | ||
| Q3 24 | 15.0% | 7.7% | ||
| Q2 24 | 7.9% | 8.4% |
现金转化率MLMSTE
| Q1 26 | 0.15× | — | ||
| Q4 25 | 2.25× | 1.55× | ||
| Q3 25 | 1.33× | 1.50× | ||
| Q2 25 | 1.18× | 2.37× | ||
| Q1 25 | 1.88× | 1.79× | ||
| Q4 24 | 2.34× | 1.92× | ||
| Q3 24 | 1.65× | 1.67× | ||
| Q2 24 | 0.00× | 2.09× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MLM
暂无分部数据
STE
| Servicerevenues | $404.7M | 27% |
| Consumablerevenues | $387.1M | 26% |
| Applied Sterilization Technologies | $286.6M | 19% |
| Capitalequipmentrevenues | $272.1M | 18% |
| Life Science | $145.8M | 10% |
